Cancer Control Journal Vol 3, No 5, CME Pretest

This Journal provides 4 hours of Category I Continuing Medical Education

Complimentary CME Credits

Physicans can earn up to 4 credit hours of Category I for the Physican's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

• Be familiar with the surgical and nonsurgical options for treating hepatocellular and metastatic tumors in the liver.
• Understand the effect of patient age on the prognosis and treatment of breast cancer.
• Be aware of the development of gene therapy for bladder cancer.
• Identify the infections related to the use of vascular access devices.

This program was planned in accordance with ACCME Essentials.
Release Date: October 1, 1996 Expiration Date: October 1, 1997

Pretest

1. What histologic characteristic is associated with a better prognosis for hepatocellular carcinoma?

a. poor tumor differentiation

b. fibrolamellar variant

c. lack of tumor capsule

d. presence of microsatellites

2. Which represents a typical post-hepatic chemoembolization syndrome?

a. vomiting, fever, abdominal pain

b. rash, hypotension, leucocytosis

c. headache, chills, diarrhea

d. confusion, dyspnea, cough

3. Which site of placement of a central venous catheter is most prone to infection?

a. subclavian

b. jugular

c. femoral

d. antecubital